Table 1 Inclusion and exclusion criteria in the OMEMI trial
Inclusion criteria | Exclusion criteria |
|---|---|
- Diagnosis of acute AMI (type I,II,IV) according to current guidelines. | - Documented intolerance for Omega-3 fatty acids. |
- Age 70–82, either gender. | - Comorbidity thought to be incompatible with compliance to study drugs. |
- Not being part of another randomized trial. | - Comorbidity thought to reduce survival for the follow-up time of 2 years. |
- Understand Norwegian and giving written consent to participate. |